WO2001098453A3 - Vecteurs d'expression comprenant un fragment modifie de l'operon tryptophane - Google Patents

Vecteurs d'expression comprenant un fragment modifie de l'operon tryptophane Download PDF

Info

Publication number
WO2001098453A3
WO2001098453A3 PCT/FR2001/001952 FR0101952W WO0198453A3 WO 2001098453 A3 WO2001098453 A3 WO 2001098453A3 FR 0101952 W FR0101952 W FR 0101952W WO 0198453 A3 WO0198453 A3 WO 0198453A3
Authority
WO
WIPO (PCT)
Prior art keywords
recombinant protein
initiation codon
construct
interest
downstream
Prior art date
Application number
PCT/FR2001/001952
Other languages
English (en)
Other versions
WO2001098453A2 (fr
Inventor
Laurent Chevalet
Original Assignee
Pf Medicament
Laurent Chevalet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament, Laurent Chevalet filed Critical Pf Medicament
Priority to US10/311,976 priority Critical patent/US20040260060A1/en
Priority to JP2002504602A priority patent/JP2004500875A/ja
Priority to EP01947565A priority patent/EP1315822A2/fr
Priority to MXPA02012880A priority patent/MXPA02012880A/es
Priority to AU69224/01A priority patent/AU6922401A/en
Priority to BR0111907-9A priority patent/BR0111907A/pt
Priority to CA002413612A priority patent/CA2413612A1/fr
Publication of WO2001098453A2 publication Critical patent/WO2001098453A2/fr
Publication of WO2001098453A3 publication Critical patent/WO2001098453A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70Vectors or expression systems specially adapted for E. coli
    • C12N15/71Expression systems using regulatory sequences derived from the trp-operon

Abstract

L'invention concerne une construction pour l'expression d'un gène codant pour une protéine recombinante d'intérêt placé sous le contrôle de l'opéron tryptophane Ptrp dans une cellule hôte procaryote, qui comprend directement en aval du codon d'initiation une séquence nucléique SEQ ID N°1 et en aval de cette séquence une cassette de clonage multiple destinée à recevoir le gène codant pour ladite protéine recombinante d'intérêt, au moins un des acides nucléiques de la séquence nucléique SEQ ID N°1 étant muté ou délété de façon à permettre une surexpression de ladite protéine recombinante. L'invention a encore pour objet un vecteur contenant une telle construction, une cellule hôte procaryote transformée par ledit vecteur, tout comme un procédé de production d'une protéine recombinante d'intérêt utilisant une construction selon l'invention.
PCT/FR2001/001952 2000-06-22 2001-06-21 Vecteurs d'expression comprenant un fragment modifie de l'operon tryptophane WO2001098453A2 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
US10/311,976 US20040260060A1 (en) 2000-06-22 2001-06-21 Constructs modified downstreams of the initiation codon for recombinant protein
JP2002504602A JP2004500875A (ja) 2000-06-22 2001-06-21 組換えタンパク質過剰発現用開始コドン下流の修飾構築体
EP01947565A EP1315822A2 (fr) 2000-06-22 2001-06-21 Vecteurs d'expression comprenant un fragment modifie de l'operon tryptophane
MXPA02012880A MXPA02012880A (es) 2000-06-22 2001-06-21 Construccion modificada hacia el extremo 3' del codon de iniciacion para sobreexpresion de proteina recombinante.
AU69224/01A AU6922401A (en) 2000-06-22 2001-06-21 Modified construct downstream of the initiation codon for recombinant protein overexpression
BR0111907-9A BR0111907A (pt) 2000-06-22 2001-06-21 Construção para a expressão de um gene, vetor, célula hospedeira, processo de produção de uma proteìna recombinante de interesse em uma célula hospedeira e utilização de uma construção e de uma proteìna recombinante
CA002413612A CA2413612A1 (fr) 2000-06-22 2001-06-21 Vecteurs d'expression comprenant un fragment modifie de l'operon tryptophane

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR00/08002 2000-06-22
FR0008002A FR2810675B1 (fr) 2000-06-22 2000-06-22 Construction modifiee en aval du codon d'initiation pour la surexpression de proteines recombinantes

Publications (2)

Publication Number Publication Date
WO2001098453A2 WO2001098453A2 (fr) 2001-12-27
WO2001098453A3 true WO2001098453A3 (fr) 2002-08-01

Family

ID=8851556

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2001/001952 WO2001098453A2 (fr) 2000-06-22 2001-06-21 Vecteurs d'expression comprenant un fragment modifie de l'operon tryptophane

Country Status (10)

Country Link
US (1) US20040260060A1 (fr)
EP (1) EP1315822A2 (fr)
JP (1) JP2004500875A (fr)
CN (1) CN1443242A (fr)
AU (1) AU6922401A (fr)
BR (1) BR0111907A (fr)
CA (1) CA2413612A1 (fr)
FR (1) FR2810675B1 (fr)
MX (1) MXPA02012880A (fr)
WO (1) WO2001098453A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2290086A3 (fr) 2004-12-22 2011-10-19 Genentech, Inc. Méthode de production de protéines multi-membranaires
EP2185704A1 (fr) * 2007-08-03 2010-05-19 Pfenex, Inc. Séquences de régions d'initiation de la traduction pour une expression optimale de protéines hétérologues
KR100961565B1 (ko) * 2008-03-10 2010-06-07 충남대학교산학협력단 목적하는 단백질 발현 수준을 제공하는 초기 코돈의발굴방법, 및 이를 이용한 재조합 단백질의 발현 조절 방법및 생산 방법
WO2009135056A2 (fr) * 2008-04-30 2009-11-05 Monsanto Technology Llc Vecteurs d’adn recombiné destinés à l’expression d’antagonistes de la prolactine humaine
AU2009266989B2 (en) * 2008-07-03 2013-05-02 Pfenex, Inc. High throughput screening method and use thereof to identify a production platform for a multifunctional binding protein
CN110491447B (zh) * 2019-08-05 2021-08-17 浙江省农业科学院 一种用于异源基因体外表达的密码子优化方法及应用
CN115960934A (zh) * 2022-08-24 2023-04-14 深圳柏垠生物科技有限公司 大肠杆菌表达外源基因优化方法及其序列

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
WO1998045427A2 (fr) * 1997-04-04 1998-10-15 Genentech, Inc. Molecules agonistes du facteur de croissance de l'insulinoide
WO1999007735A2 (fr) * 1997-08-07 1999-02-18 Creative Peptides Sweden Ab Expression recombinee du peptide c de l'insuline

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772555A (en) * 1985-03-27 1988-09-20 Genentech, Inc. Dedicated ribosomes and their use
US5149792A (en) * 1989-12-19 1992-09-22 Amgen Inc. Platelet-derived growth factor B chain analogs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4738921A (en) * 1984-09-27 1988-04-19 Eli Lilly And Company Derivative of the tryptophan operon for expression of fused gene products
WO1998045427A2 (fr) * 1997-04-04 1998-10-15 Genentech, Inc. Molecules agonistes du facteur de croissance de l'insulinoide
WO1999007735A2 (fr) * 1997-08-07 1999-02-18 Creative Peptides Sweden Ab Expression recombinee du peptide c de l'insuline

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MERINO E. ET AL.: "trp RNA-Binding Attenuation Protein (TRAP)-trp Leader RNA Interactions Mediate Translational as well as Transcriptional Regulation of the Bacillus subtilis trp Operon", JOURNAL OF BACTERIOLOGY, vol. 177, no. 22, November 1995 (1995-11-01), pages 6362 - 6370, XP002163024 *
SAMBROOK J. ET AL.: "Molecular Cloning A Laboratory Manual", 1987, MOLECULAR CLONING A LABORATORY MANUAL, NEW YORK,COLD SPRING HARBOUR PRESS,US, XP002191819 *
WILSON ET AL: "Increased Protein Expression Through Improved Ribosome-Binding Sites Obtained by Library Mutagenesis", BIOTECHNIQUES, vol. 17, no. 5, 1994, pages 944 - 953, XP002161835, ISSN: 0736-6205 *

Also Published As

Publication number Publication date
CN1443242A (zh) 2003-09-17
CA2413612A1 (fr) 2001-12-27
JP2004500875A (ja) 2004-01-15
US20040260060A1 (en) 2004-12-23
AU6922401A (en) 2002-01-02
EP1315822A2 (fr) 2003-06-04
WO2001098453A2 (fr) 2001-12-27
FR2810675A1 (fr) 2001-12-28
FR2810675B1 (fr) 2002-09-27
BR0111907A (pt) 2003-12-30
MXPA02012880A (es) 2003-05-14

Similar Documents

Publication Publication Date Title
KR860001305B1 (ko) 특이적 절단 링커를 사용하는 융합 단백질의 제조방법
WO2000020555A3 (fr) Systeme de transformation dans le domaine des hotes fongiques filamenteux
WO2004064750A3 (fr) Constructions ameliorees permettant d'exprimer des polypeptides lysosomiaux
EP0784059A4 (fr) Polypeptide antigenique de chlamydia pneumoniae
HK1114636A1 (en) 1l-17 homologous polypeptides and therapeutic uses thereof
DE602005020972D1 (en) Rhamnosepromotor-expressionssystem
EP0963435A4 (fr) Procedes de production de proteines
WO2001000842A3 (fr) Genes de corynebacterium glutamicum codant des proteines impliquees dans l'homeostase et adaptation
EP0889133A3 (fr) Procédé de préparation de transglutaminase microbienne
WO2003060143A3 (fr) Systeme d'expression de proteine efficace
WO2001098453A3 (fr) Vecteurs d'expression comprenant un fragment modifie de l'operon tryptophane
WO2001044276A3 (fr) Genes de mousse de physcomitrella patens codant pour des proteines impliquees dans la synthese de tocopherols et de carotenoides
WO2003074657A3 (fr) Expression inductible par choc thermique et production de polypeptides heterologues
WO2003040391A3 (fr) Procede de production et d'identification de domaines proteiques solubles
EP0887410A3 (fr) ADN codant une protèine activant le plasminogène
WO2001029224A3 (fr) Homologue zgpa1 de peptide de granulocyte
EP0750040A3 (fr) Variants de la protéine stimulatrice des macrophages et procédés de fabrication
SE0303093D0 (sv) Expression vector, host cell and method for producing fusion proteins
EP0845536A3 (fr) Protéine à activité de l'acide éthylènediamine-N-N'-succinique: éthylènediamine lyase et ADN codant pour celle-ci
IL139272A0 (en) New peptide fragments for protein purification
Kim et al. High-level expression of human α s1-casein in Escherichia coli
WO2001070986A3 (fr) Proteine helicoidale zalpha51
WO1992020806A3 (fr) Vecteur d'expression de dictyostelides et procede d'expression d'une proteine desiree
WO2001025401A3 (fr) Utilisation d'une sequence codante de mycobacterium tuberculosis pour favoriser une expression stable et de fort rendement de proteines heterologues
WO2000037492A3 (fr) ACIDES NUCLEIQUES huHDGFH, POLYPEPTIDES, PROCEDES ET UTILISATIONS DE CEUX-CI

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU BR CA CN JP MX US ZA

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AU BR CA CN JP MX US ZA

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: PA/a/2002/012880

Country of ref document: MX

WWE Wipo information: entry into national phase

Ref document number: 2413612

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001947565

Country of ref document: EP

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2002 504602

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 018129889

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 69224/01

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003/00550

Country of ref document: ZA

Ref document number: 200300550

Country of ref document: ZA

WWP Wipo information: published in national office

Ref document number: 2001947565

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10311976

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001947565

Country of ref document: EP